Product Information
ILEVRO 0.3% OPHTH DROPS is a brand product labeled by Harrow Eye, LLC, priced at $121.1218 per ML under NDC 82667040003. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
3 mg/mL
Manufacturer
Harrow Eye, LLCNDC
82667040003
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
NEPAFENACApproval Type
New Drug (NDA)
FDA Application
NDA203491On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ILEVRO 0.3% OPHTH DROPS has been published 67 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $121.1218 per ML |
|---|---|
| All-time high | $121.4644 (May 14, 2025) |
| All-time low | $120.9348 (Aug 20, 2025) |
| 52-week high | $121.2435 |
| 52-week low | $120.9348 |
| Median price | $121.1309 |
| Average price | $121.1436 |
| Largest weekly change | -0.4% (May 21, 2025) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the nepafenac market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ILEVRO 0.3% OPHTH DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ILEVRO 0.3% OPHTH DROPS, manufactured by Harrow Eye, LLC, is $121.1218 per ML (NDC 82667040003), effective Jun 24, 2026.
How has the price of ILEVRO 0.3% OPHTH DROPS changed over time?
Over the history we have for it, the NADAC for ILEVRO 0.3% OPHTH DROPS has held within roughly two percent of its current level. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for ILEVRO 0.3% OPHTH DROPS?
Since Mar 19, 2025, the NADAC for ILEVRO 0.3% OPHTH DROPS has ranged from a low of $120.9348 (Aug 20, 2025) to a high of $121.4644 (May 14, 2025), with a median of $121.1309 per ML.
Are there cheaper alternatives to ILEVRO 0.3% OPHTH DROPS?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ILEVRO 0.3% OPHTH DROPS, so no direct lower-cost alternative is listed.
Who manufactures ILEVRO 0.3% OPHTH DROPS?
ILEVRO 0.3% OPHTH DROPS (NDC 82667040003) is labeled by Harrow Eye, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification